Abstract
Validation of quantitative structure-activity relationship (QSAR) models plays a key role for the selection of robust and predictive models that may be employed for further activity prediction of new molecules. Traditionally, QSAR models are validated based on classical metrics for internal (Q2) and external validation (R2 pred). Recently, it has been shown that for data sets with wide range of the response variable, these traditional metrics tend to achieve high values without truly reflecting absolute differences between the observed and predicted response values, as in both cases the reference for comparison of the predicted residuals is the deviations of the observed values from the training set mean. Roy et al. have recently developed a new parameter, modified r2 (rm 2), which considers the actual difference between the observed and predicted response data without consideration of training set mean thereby serving as a more stringent measure for assessment of model predictivity compared to the traditional validation parameters (Q2 and R2 pred). The rm 2 parameter has three different variants: (i) rm 2 (LOO) for internal validation, (ii) rm 2 (test) for external validation and (iii) rm 2 (overall) for analyzing the overall performance of the developed model considering predictions for both internal and external validation sets. Thus, the rm 2 metrics strictly judge the ability of a QSAR model to predict the activity/toxicity of untested molecules. The present review provides a survey of the development of different rm 2 metrics followed by their applications in modeling studies for selection of the best QSAR models in different reports made by several workers.
Keywords: QSAR, rm2 metrics, Internal validation, external validation, ecotoxicological, LOO-Q2, LOO, R2 pred, Saccharomyces cerevisiae, physicochemical descriptors, Tetranychus urticae
Mini-Reviews in Medicinal Chemistry
Title:On the Use of the Metric rm 2 as an Effective Tool for Validation of QSAR Models in Computational Drug Design and Predictive Toxicology
Volume: 12 Issue: 6
Author(s): K. Roy and I. Mitra
Affiliation:
Keywords: QSAR, rm2 metrics, Internal validation, external validation, ecotoxicological, LOO-Q2, LOO, R2 pred, Saccharomyces cerevisiae, physicochemical descriptors, Tetranychus urticae
Abstract: Validation of quantitative structure-activity relationship (QSAR) models plays a key role for the selection of robust and predictive models that may be employed for further activity prediction of new molecules. Traditionally, QSAR models are validated based on classical metrics for internal (Q2) and external validation (R2 pred). Recently, it has been shown that for data sets with wide range of the response variable, these traditional metrics tend to achieve high values without truly reflecting absolute differences between the observed and predicted response values, as in both cases the reference for comparison of the predicted residuals is the deviations of the observed values from the training set mean. Roy et al. have recently developed a new parameter, modified r2 (rm 2), which considers the actual difference between the observed and predicted response data without consideration of training set mean thereby serving as a more stringent measure for assessment of model predictivity compared to the traditional validation parameters (Q2 and R2 pred). The rm 2 parameter has three different variants: (i) rm 2 (LOO) for internal validation, (ii) rm 2 (test) for external validation and (iii) rm 2 (overall) for analyzing the overall performance of the developed model considering predictions for both internal and external validation sets. Thus, the rm 2 metrics strictly judge the ability of a QSAR model to predict the activity/toxicity of untested molecules. The present review provides a survey of the development of different rm 2 metrics followed by their applications in modeling studies for selection of the best QSAR models in different reports made by several workers.
Export Options
About this article
Cite this article as:
Roy K. and Mitra I., On the Use of the Metric rm 2 as an Effective Tool for Validation of QSAR Models in Computational Drug Design and Predictive Toxicology, Mini-Reviews in Medicinal Chemistry 2012; 12 (6) . https://dx.doi.org/10.2174/138955712800493861
DOI https://dx.doi.org/10.2174/138955712800493861 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Medicinal Chemistry and Biological Properties of Non-Imidazole Histamine H3 Antagonists
Mini-Reviews in Medicinal Chemistry The Stress of the COVID-19 Pandemic: Beyond the Data
Current Neuropharmacology Systematic Reviews of Animal Experiments Demonstrate Poor Contributions Toward Human Healthcare
Reviews on Recent Clinical Trials Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine Development
Current Medicinal Chemistry Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
Current Molecular Medicine Advances in Synthesis, Derivatization and Bioactivity of Isatin: A Review
Current Organic Synthesis The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis Small Molecule Peptidomimetic Ligands of Neurotrophin Receptors, Identifying Binding Sites, Activation Sites and Regulatory Sites
Current Pharmaceutical Design Psychiatry Research has Moved Past COVID-19
Current Psychiatry Research and Reviews 3D QSAR Pharmacophore Modeling for c-Met Kinase Inhibitors
Medicinal Chemistry Molecular Modeling Studies of Novel Fluoroquinolone Molecules
Current Drug Discovery Technologies Transdermal Anti-inflammatory Delivery for Solid Lipid Nanoparticles of Ketoprofen by Microwave-assisted Microemulsion
Recent Advances in Inflammation & Allergy Drug Discovery Inhibitors for Proteins Endowed with Catalytic and Non-Catalytic Activity which Recognize pTyr
Current Medicinal Chemistry New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Recovery of Locomotor Function with Combinatory Drug Treatments Designed to Synergistically Activate Specific Neuronal Networks
Current Medicinal Chemistry A Novel Supperparamagnetic Heterogeneous Organocatalyst for the Efficient Synthesis of 3,3-́ diaryloxindoles
Current Organocatalysis Targeted Therapies in Combination with Radiotherapy in Oesophageal and Gastroesophageal Carcinoma
Current Medicinal Chemistry Potential Applications of <i>Sarcopoterium Spinosum</i> as Medicinal Plants: Overview and Future Trends
Current Traditional Medicine Black Tea Polyphenols-Mediated In Vivo Cellular Responses During Carcinogenesis
Mini-Reviews in Medicinal Chemistry NRF2-Dependent Glutamate-L-Cysteine Ligase Catalytic Subunit Expression Mediates Insulin Protection Against Hyperglycemia-Induced Brain Endothelial Cell Apoptosis
Current Neurovascular Research